Sign in
4

Changes in Ownership

UNITED THERAPEUTICS Corp Filed Acc 0001231427-26-000002

Director sold 2,910 shares at $569.00 ($1,655,790)

  • Director acquired 2,910 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

PATUSKY CHRISTOPHER · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-04-24 Exercise or conversion : show line 1 in the form 10b5-1 +2,910 $101.80 $296,238 4,400 D
2026-04-24 Sale : show line 2 in the form 10b5-1 −2,910 $569.00 $1,655,790 1,490 D
Open-market sales · 2,910 sh · avg $569.00 · $1,655,790

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-04-24 Exercise or conversion : show line 3 in the form 10b5-1 Stock Option −2,910 0 D
Loading xslF345X06/primarydocument.xml…